LECT2 and kidney disorder: With access to novel diagnostic approaches, advances in biochemical tissue analysis have identified leukocyte chemotactic factor 2 (LECT2) as a novel subtype of amyloid causing kidney disease, primarily among Hispanic persons in the Southwest region of the United States [30–32].